Biological context {#Sec1}
==================

Bet v 1 is a highly immunogenic protein that represents the main cause for allergic sensitization against birch pollen (Ipsen and Lowenstein [@CR6]). In the temperate climate zone of the northern hemisphere, an estimated 100 million people are allergic to birch pollen, up to 90% of individuals that are sensitized to birch pollen exhibit serum IgE reactivity towards Bet v 1 (Moverare et al. [@CR10]). This allergen belongs to the family of pathogenesis-related proteins of class 10 (PR-10), which are found in a multitude of different plants (Fernandes et al. [@CR2]). The exact function of these proteins is still unknown, but a key role in defence of plants is assumed, as they are encoded by genes that are activated in response to different kinds of abiotic and biotic stress.

Naturally occurring Bet v 1 is a composition of different isoforms with a molecular mass around 17.5 kDa, which share high sequential identities but can have a drastically different allergenic potential (Ferreira et al. [@CR3]). To date more than twenty isoforms are listed by the IUIS Allergen Nomenclature Sub-Committee (<http://www.allergen.org>). With 35% of total Bet v 1 in grained pollen, the hyperallergenic isoform Bet v 1.0101 (Bet v 1a) is the most abundant one (Ferreira et al. [@CR3]). Experiments with sera of birch pollen allergic individuals showed that Bet v 1.0101 has the ability to induce a high level of IgE antibody production, which results in type I allergic reactions (Wagner et al. [@CR14]). This is contrasted by Bet v 1.0102 (Bet v 1d), which possesses a sequence identity of 95.6% to Bet v 1.0101 but activates IgG4 expression (Wagner et al. [@CR14]). The hyperallergenic isoform Bet v 1.0101 thus plays an important role for allergic sensitization, while the hypoallergenic Bet v 1.0102 initiates the defending immune response. Furthermore, hypoallergenic isoforms are potential candidates for allergen-specific immunotherapy (Valenta et al. [@CR12]). Very recent studies hypothecate that these different immunological properties may result from a varying dynamical behavior and fold stabilities (Freier et al. [@CR4]; Machado et al. [@CR8]).

The three-dimensional structures of numerous Bet v 1 isoforms and mutants are available in the literature (Fernandes et al. [@CR2]). Bet v onefolds into a curved seven-stranded antiparallel β-sheet, along with two short α-helices and an extended C-terminal helix, which create an expanded internal cavity, as it is typical for the PR-10 protein family. Of note, Bet v 1 structures that are available in the protein data base (PDB) exhibit only small differences, with backbone pair-wise rmsd values between 1.5 and 2 Å. For Bet v 1.0102 a three-dimensional structure has not been reported so far. Homologous PR-10 proteins found in fruits and vegetables with similar three-dimensional structures can elicit allergic cross-reactions with Bet v 1-specific IgE antibodies, including apples, cherries, peaches and others (Mills and Shewry [@CR9]).

Here we present the solution NMR backbone and side chain assignment of hypoallergenic Bet v 1.0102 and a chemical shift-derived three-dimensional structure model of this protein created by CS-Rosetta. Chemical shift assignments of Bet v 1 are the prerequisite for future NMR dynamics studies of this protein.

Methods and experiments {#Sec2}
=======================

Protein expression and purification {#Sec3}
-----------------------------------

For recombinant protein production the vector pET28b containing codon-optimized DNA of Bet v 1.0102 was used. The expression and purification protocol was adapted from Wallner et al. ([@CR15]). Protein expression in *E. coli* strain BL21 (DE3) Star was carried out in 1 l M9 minimal medium including 25 µg/ml kanamycin enriched with ^15^NH~4~Cl (Cambridge Isotope Laboratories) and ^13^C~6~-[d]{.smallcaps}-glucose (Sigma-Aldrich) for isotope labeling at 37 °C. After induction with 0.5 mM IPTG at OD~600~ = 0.6--0.8, the culture was grown overnight at 16 °C and harvested by centrifugation at 2050×*g*. For cell resuspension a buffer containing 25 mM imidazole, 0.1% (v/v) Triton ×100 and 0.5 M urea was used. The cells were lysed by three cycles of freezing (liquid nitrogen) and thawing (water bath at 37 °C). First, DNAse I (1 µg/ml) and after 20 min of shaking, solid NaCl was added to a final concentration of 200 mM. The mixture was centrifuged at 9500×*g* for 30 min and the supernatant was collected. Under constant stirring on ice solid NaCl and NaH~2~PO~4~ were slowly added to a concentration of 1 and 0.5 M, respectively. After 2 h of stirring the precipitated proteins were collected at 9500×*g* for 30 min and the supernatant containing Bet v 1.0102 was filtered through a 45 µm filter. Bet v 1.0102 was purified by hydrophobic interaction chromatography using 3 × 5 ml phenylsepharose columns (HiTrap™ Phenyl FF, GE Healthcare) at a flow rate of 2 ml/min. After the protein solution was loaded, a linear gradient of 30 ml with 0.2 M NaH~2~PO~4~ and 1 M NaCl, pH 4.2 was performed to remove urea. For protein elution, a linear gradient of 180 ml using 25 mM TrisHCl pH 9.3, 8% (v/v) 2-propanol was applied. Bet v 1.0102 containing fractions were collected and concentrated by Amicon Ultra Centrifugal Filters with a cut-off of 3000 Da (Millipore). As final purification step size exclusion chromatography was performed using a 120 ml gel filtration column (HiLoad 16/600 Superdex 75 prep grade, GE Healthcare) with 5 mM sodium phosphate buffer, pH 8.0 at a flow rate of 1 ml/min. An ÄKTAprime™ plus chromatography system (GE Healthcare) was used for all chromatographic steps with an integrated UV-detector for protein detection at 280 nm. The protein concentration was determined using a NanoPhotometer^®^ (Implen). Expression and purification of Bet v 1.0102 were monitored by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS--PAGE) using 15% gels. Purified Bet v 1.0102 was dialyzed against 50 mM NaCl, 10 mM sodium phosphate buffer, pH 7.0 for NMR resonance assignment experiments.

NMR spectroscopy {#Sec4}
----------------

The following spectra were recorded for NMR resonance assignment on a 500 MHz Agilent DirectDrive spectrometer at 298 K: 2D ^1^H-^15^N-HSQC, ^1^H-^13^C-HSQC, and 3D HNCO, HNCACB, CBCA(CO)NH, (H)CC(CO)NH-TOCSY, H(CC)(CO)NH-TOCSY, and ^1^H^15^N-HSQC-TOCSY. The protein concentration for these NMR measurements was 0.8 mM of ^15^N/^13^C labeled Bet v 1.0102 in 10 mM sodium phosphate, 50 mM NaCl, 90% H~2~O/10% D~2~O (v/v) at pH 7.0. Data processing was done using NMRPipe (Delaglio et al. [@CR1]) and for resonance assignment the program CcpNmr Analysis (Vranken et al. [@CR13]) was used.

Assignment and secondary structure {#Sec5}
----------------------------------

The ^1^H-^15^N-HSQC spectrum of Bet v 1.0102 is shown in Fig. [1](#Fig1){ref-type="fig"}. Backbone amide ^1^H-^15^N resonance assignment was obtained for 143 out of 151 non-proline residues, which corresponds to 94.7%. In addition, 96.9% of Cα, 96.9% of Cβ and 94.0% of CO resonances were assigned, and assignment of side chain protons is 87.4% complete. Furthermore, side-chain ^13^C resonances beyond β-positions and side-chain amides in Asn and Glu (^15^N and ^1^H) were assigned partially. The chemical shift data of Bet v 1.0102 have been deposited at the Biological Magnetic Resonance Data Bank (BMRB) with the accession number 27040.

Fig. 1Assigned ^1^H-^15^N-HSQC spectrum of Bet v 1.0102 in 10 mM sodium phosphate, 50 mM NaCl, 10% D~2~O at pH 7.0, 298 K, 500 MHz. NH~2~ side chain resonances are connected by *horizontal lines. Asterisks* indicate the positions of residues below the intensity cut-off

Using the Bet v 1.0102 chemical shifts (HN, N, Cα, Cβ and CO), the secondary structure elements of the protein were predicted by TALOS+ (Shen et al. [@CR11]) (Fig. [2](#Fig2){ref-type="fig"}a). Our data show that this protein contains seven β-strands (β1−β7) and two short helices (α1−α2), as well as a long C-terminal helix (α3). In addition, a three-dimensional model of the protein was generated using CS-ROSETTA (Lange et al. [@CR7]) (Fig. [2](#Fig2){ref-type="fig"}b). In this structure, Bet v 1.0102 consists of a long C-terminal helix that is embraced by a curved, seven-stranded antiparallel β-sheet. Helices α1 and α2 form a V-shaped support for helix α3, creating a large internal cavity, consistent with the canonical PR-10 fold (Fernandes et al. [@CR2]).

Fig. 2**A** TALOS+ prediction of secondary structure elements of Bet v 1.0102 derived from HN, N, Cα, Cβ and CO chemical shifts. The secondary structure probability is reflected by the *height of the bars* (*blue* β-strands, *red* α-helices). Unassigned backbone amide NH resonance are indicated by *asterisks*. For comparison, the secondary structure elements of Bet v 1.0101 (*α1*--*α3* and *β1*--*β7*) are *shown above*. **B** Lowest energy CS-ROSETTA structure model of Bet v 1.0102. Amino acids that are different in Bet v 1.0102 compared to Bet v 1.0101 are *highlighted in red* (T7I, F30V, S57N, I91V, S112C, I113V, D125N)

Taken together, the Bet v 1.0102 chemical shift data indicate no significant structural difference between the hypoallergenic isoform Bet v 1.0102 and the hyperallergenic isoform Bet v 1.0101 (Gajhede et al. [@CR5]). However, the observed variability in resonance intensities is an indication for the dynamic nature of this protein. A detailed NMR spectroscopic investigation of the dynamic properties of Bet v 1 proteins in the context of their observed immunologic features is currently being performed at our laboratory. In addition, the NMR chemical shift assignments of Bet v 1.0102 build the basis for epitope mapping and ligand binding studies.
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